In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia
Open Access
- 26 October 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 1176
Abstract
Cystic fibrosis (CF) is a chronic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, which encodes for a channel expressed at the apical surface of epithelial tissues. Defective chloride and bicarbonate secretion, arising from CFTR mutations, cause a multi-organ disease. In the airways, impaired ion transport results in a thick mucus, dehydration of the periciliar region and bacterial infections. Over the last years, basic research has sustained a great effort to identify therapies that are able to correct defective CFTR. For this purpose, in vitro cell models have played a key role in the study of mechanisms of the disease and to assess CFTR modulator therapies. Cultures of human primary bronchial epithelia are considered a physiologically relevant disease model due to their ability to maintain most of the morphological and functional characteristics of the airway epithelium in vivo. Despite their value, these cells are limited by the availability of human lung tissue and by the complexity of the culture procedure. However, primary human nasal cells can be considered as an alternative model for the study of CF pathophysiology since they are easier to obtain and recapitulate the properties of bronchial cultures. Over the years, several groups have optimized a protocol with key steps to culture and fully amplify differentiated primary airway epithelia. Our approach provides epithelia monolayers grown on porous filters, characterized by high transepithelial electrical resistance and an electrical potential difference. These parameters are required to perform electrophysiological experiments devoted to the study of ion transport mechanisms in airway epithelia. The aim of this study was to describe different methods to expand and differentiate isolated cells into fully polarized monolayers of airway epithelium, in order to provide an optimized protocol to support physiopathology analysis and to evaluate therapeutic strategies.Keywords
This publication has 28 references indexed in Scilit:
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulatorsScientific Reports, 2017
- Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2017
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTRNew England Journal of Medicine, 2015
- Radiation Induces Diffusible Feeder Cell Factor(s) That Cooperate with ROCK Inhibitor to Conditionally Reprogram and Immortalize Epithelial CellsThe American Journal of Pathology, 2013
- Mechanism-based corrector combination restores ΔF508-CFTR folding and functionNature Chemical Biology, 2013
- Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasiaThe Journal of Physiology, 2012
- Primary Human Bronchial Epithelial Cells Grown from ExplantsJournal of Visualized Experiments, 2010
- Nasal Epithelial Cells as Surrogates for Bronchial Epithelial Cells in Airway Inflammation StudiesAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- An improved method to obtain highly differentiated monolayers of human bronchial epithelial cellsIn Vitro Cellular & Developmental Biology - Animal, 1998
- Spontaneous production of transforming growth factor-beta 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro.Journal of Clinical Investigation, 1992